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Abstract: Mast cell contribution to neoangiogenesis during tumorigenesis in oral squamous cell carcinoma is not deter-
mined yet. Objectives: To associate numerical mast cell density (MCD) to numerical microvessel density (MVD) during 
the progression of oral leukoplakia without dysplasia and leukoplakia with dysplasia to squamous cell carcinoma (OSCC). 
Materials and methods: MVD was analysed immunohistochemically (mouse monoclonal anti-human CD34) in 49 paraf-
fin-embedded specimens, 35 OSCCs, 9 leukoplakias and 5 normal oral tissues. Toluidine blue counterstaining revealed 
mast cells. MCD and MVD were assessed at the same optical field. Results: MVD increased between: normal oral mu-
cosa, dysplasia (p=0.004), OSCC (p=0.001), leukoplakia and OSCC (p=0.041). MCD increased between: normal oral mu-
cosa, dysplasia (p=0.003), OSCC (p=0.000), leukoplakia and OSCC (p=0.007). MVD was found to depend on MCD 
(p=0.000) in a percent 28.3% (power curve fit model). Conclusions: Mast cells are attracted at the lesion site and may turn 
on an angiogenic switch during tumorigenesis in OSCC. 
INTRODUCTION 
  Mast cells are phylogenetically old, highly granulated 
cells, already known by their key role in type I hypersensi-
tivity reaction [1]. They are the main effector cells in IgE-
associated disorders but also seem to play important roles in 
acquired or innate host reactions [2]. Mast cells can release 
numerous pro-inflammatory, immunoregulatory and angio-
genic molecules through different stimulation pathways [3]. 
The activation of mast cells has been proved to have many 
biological consequences such as mitogenesis, extracellular 
matrix degradation, angiogenesis and augmentation of micro- 
vascular hyperpermeability [4] and recruitment of inflamma- 
tory cells including macrophages. It is already known that 
neoangiogenesis is required for the growth and spread of 
tumors [5]. Increased angiogenesis has been associated with 
neoplastic progression, metastasis and outcome in several 
studies and in a number of malignancies [6-12]. Recent data 
suggest that the acummulation of mast cells around the 
tumor margins and their release of potent pro-angiogenic and 
angiogenic factors may represent a tumor-host interaction 
which probably favors tumor progression  [13-15]. The ac-
cummulation of mast cells is usually estimated by counting 
the mast cell density, which is the number of mast cells per 
optical field in tissue sections [16]. The contribution of mast 
cells, however, to angiogenesis during the progression from 
oral leukoplakia without dysplasia to oral leukoplakia with 
dysplasia or oral squamous cell carcinoma is not clear yet, 
due to conflicting results within the literature [14, 17].  
  The purpose of the current study was to examine the rela-
tionship between mast cells, angiogenesis and
 the histologi-
cal progression from normal oral tissues through leukoplakia 
lesions with various degrees of dysplasia to OSCC.
 We ana-
lyzed, therefore, mast cell density and microvessel density in  
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oral leukoplakia without dysplasia, oral leukoplakia with 
mild moderate or severe dysplasia dysplasia and oral 
squamous cell carcinoma.  
MATERIALS AND METHODS 
Tissue Specimens 
  Fourty-nine (49) formalin-fixed, paraffin-embedded tis-
sue specimens obtained from oral biopsies, were retrieved 
from the archives of the histopathology laboratory from the 
Department of Oral Medicine and Maxillofacial Pathology. 
The tissue specimens were: 30 oral squamous cell carcino-
mas, 7 leukoplakias without dysplasia and 12 leukoplakias 
with dysplasia (4 with mild, 4 with moderate and 4 with se-
vere dysplasia). Five samples from normal oral tissue were 
used as a control group.  
  In order to focus on the early stages of head and neck 
cancer, the selection criteria included: Newly diagnosed pa-
tients, who visited the Department of Oral Medicine and 
Maxillofacial Pathology during the period from 2000 to 2007 
and invasive squamous cell carcinomas characterized as 
T1N0M0 or T2N0M0, according to the TNM staging system. 
The TNM stage was determined after a complete radio-
graphic examination of the patients and the surgical excision 
of the lesions. The diagnosis was based on the clinical ex-
amination and the histopathologic
 analysis of the specimens. 
The clinical diagnosis of leukoplakia was given to any white 
patch or plaque that could not be characterized clinically or 
pathologically as any other disease or condition such as li-
chen planus, chronic cheek bite, frictional keratosis, tobacco 
keratosis, nicotine stomatitis, leukoedema and white sponge 
naevus. Histopathologically leukoplakia lesions were charac-
terized by a thickened keratin layer of the surface epithelium 
and/or a thickened spinous layer
  [18].  The diagnosis of 
epithelial dysplasia was based on the criteria described in the 
report from the WHO international collaborating center for 
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  The recorded clinical and histopathologic data included 
age, gender,
 clinical lesion stage, site of the lesion and histo-
pathologic differentiation. The study was conducted accord-
ing to the Helsinki declaration. 
  From each paraffin block, two tissue sections, 4 m thick 
each, were placed on a slide. 
Determination of Numerical Microvessel Density 
  In order to assess microvessel density, immunohisto- 
chemistry staining was conducted. Upon one out of the two 
tumor sections on each slide, a mouse monoclonal anti-
human CD34 Class II antibody (clone QBEnd-10) (Dako 
Cytomation) (Glostrup, Denmark) was applied. The second 
tissue section in each slide was stained with anti-mouse IgG1 
antibody {(mAb, Mouse IgG1 (MOPC21), Sigma-Aldrich 
Co., Steinheim, Germany)} to serve as an internal negative 
control. Formalin-fixed, paraffin-embedded
 human sarcoma 
Kaposi tissue known to highly express CD34 was used as an 
internal
 positive control for the measurements of CD34 ex-
pression. Tissue samples were deparaffinized in xylene and 
rehydrated
 with graded alcohols. Incubation of the slides in 
1% hydrogen peroxide (H2O2) with
 methanol for 30 minutes 
blocked the endogenous peroxidase activity. The slides were 
then washed with TBS (Triphosphate buffered saline). To 
retrieve antigen epitopes, tissue sections were heated in cit-
ric-acid buffer, at pH 6.7, for 10 minutes in a microwave 
oven. The slides were then left to cool at room temperature 
for 20 minutes. The anti-CD34 antibody was diluted (1:50) 
and applied on the tissue sections for one hour at room tem-
perature. Immunostaining was then performed using the En-
vision system (Envision HRP, Mouse/Rabbit detection sys-
tem) (Dako, Glostrup, Denmark). Afterwards diamino-
benzidine chromogen (DAB chromogen) was applied.  
Counterstaining with Toluidine Blue for Determination 
of Numerical Mast Cell Density  
  The tissue sections, after the immunohistochemical stain-
ing, instead of being counterstained with hematoxylin, they 
were counterstained with toluidine blue. The slides were 
quickly dipped 15 times in a 0.1% tolouidine blue solution 
and then were washed in tap water to remove excess chro-
mogen. Afterwards, the slides were quickly dipped once in a 
solution containing 70% alcohol and 0.5% HCl and were 
dried by firmly pressing them once, against a suitable ab-
sorbent paper. They were then washed twice, by 12 dipps 
each time in xylene and were mounted with entalan. Tolu-
idine blue reveals the mast cells [21, 22]. 
  Using this technique, mast cells and microvessels can be 
observed together at the same slide (Fig. 5). The number of 
mast cells and microvessels were then counted together, at 
the same optical field.  
Verification of Mast Cell Density Count 
  In the above tissue sections, the number of mast cells was 
counted twice in three optical fields using a magnification 
x200 (20x objective and 10x occular lens, 0.785mm
2 per 
field)  and the mean number of mast cells was estimated. 
Separate tissue sections from the same tissue blocks were 
stained with toluidine blue alone. The number of mast cells 
in three optical fields using a magnification x200 was also 
counted twice and the mean number of mast cells was esti-
mated to ensure that the same number of mast cells were 
stained using the simple toluidine blue stainining technique 
and the counterstaining technique. 
Numerical Microvessel Density Assessment 
  The area of optimal staining for microvessels was 
marked using a magnification x100. Within the marked area, 
at x400 (40x objective and 10x occular lens, 0.785mm
2 per 
field)
  magnification and with a one-field depth from the 
basement membrane
  of the epithelium or from the tumor 
invasive margins or from the tumor nests, three microscopic 
fields, having the larger number of microvessels, were se-
lected and assesed. Microvessel density was defined as the 
number of stained microvessels per optical field. Any single 
stained endothelial cell or endothelial cell cluster, clearly 
separated from adjacent microvessels, tumor cells,
 and other 
connective tissue elements was considered a single,
  count-
able microvessel [12]. When different degrees of dysplasia 
were observed at the same tissue section, microscopic fields 
around the most severe lesion were selected. Necrotic areas, 
within the tumor sections were avoided.  
Numerical Mast Cell Density Assessment  
  At the three already selected microscopic fields, having 
the larger number of microvessels, at x400
 magnification and 
with a one-field depth from the basement membrane
 of the 
epithelium, the number of mast cells was counted. Mast cell 
density was defined as the number of stained mast cells per 
optical field. 
Statistical Analysis  
  Statistical analysis using the statistical package SPSS 13 
(Chicago, Illinois), was performed. In order to test the differ-
ences concerning microvessel density (MVD) and mast cell 
density (MCD) between any two groups of patients the Bon-
feroni test, after ANOVA, was used at a significance level of 
p < 0.05. To test if there was a correlation between mast cell 
density (number of mast cells per optical field) (MCD) and 
the number of microvessels per optical field (MVD), regres-
sion analysis (within the generalized linear models) was per-
formed and the curve fit model was estimated.  
RESULTS 
Patients and Tissue Characteristics 
  Out of the 49 patients: 36 were men and 13 women. The
 
average age of these patients was 60.38±14.99 years, with a 
range of
 26-87 years. Primary tumor sites were: the
 vermilion 
border, the buccal mucosa, the tongue, the floor of the mouth 
and other sites within the oral cavity (Tables 1,2). 
Numerical Microvessel Density  
  In normal oral epithelium, leukoplakia without dysplasia 
and leukoplakia with dysplasia
  lesions, microvessels are 
mainly located just underneath the
  epithelium and were 
stained as brown spots, lines or lumens. MVD was counted 
in every tissue. In normal oral tissues the mean MVD was 
14.08, in leukoplakia without dysplasia 18.18, in leukoplakia 
with dysplasia 21.79 and in OSCC 24.78. The number of 
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tween: Normal oral mucosa and leukoplakia with mild 
(p=0.022), and severe dysplasia (p=0.04) and also between 
normal oral mucosa and OSCC (p=0.000). The number of 
microvessels was also found to be increased significantly 
between: leukoplakia without dysplasia (p=0.042), leu-
koplakia with mild (p=0.033), moderate (p=0.010), severe 
dysplasia (p=0.04) and OSCC, but it was not significantly 
increased between leukoplakia with severe dysplasia and 
OSCC (p=0.262) (Table 1, Figs. 1,2,3,4). No correlation was 
found between the microvessel density and the age of the 
patients (mean= 22.8 and p=0.30) or the site of the primary 
tumor (mean=23 and p=0.247). 
Numerical Mast Cell Density 
  Toluidine blue staining revealed mast cells as large, pur-
ple, oval and highly granulated cells (Fig. 5). Mast cells were 
observed at the lamina propria highly populating areas 
around the tumor margins. Mast cells were also observed at 
the tumor periphery and at the stem of the lesion when this 
existed. Increased numbers of mast cells were also found in 
areas of high vascularization (namely the ‘hot spots’). MCD 
was counted in every tissue. In normal oral tissues the mean 
MCD was 1.32, in leukoplakia without dysplasia 4.55,   
in leukoplakia with dysplasia 7.11 and in OSCC 9.33. The 
number of mast cells was found to be increased significantly 
between: normal oral mucosa and leukoplakia with mild 
(p=0.02), moderate (p=0.011) and severe dysplasia (p=0.029) 
and also normal oral mucosa and OSCC (p=0.000). The 
number of mast cells was also found to be increased signifi-
cantly between: leukoplakia with severe dysplasia and 
OSCC (p=0.05) (Table 1 and Figs. 1,2,3,4). No correlation 
was found between the microvessel density and the age of 
the patients (mean= 22.8 and p=0.30) or the site of the pri-
mary tumor (mean=23 and p=0.247). 
Correlation Between MCD and MVD 
  The number of microvessels was found to depend sig-
nificantly on the number of mast cells (p=0.000) in a percent 
28.3%, following the power curve fit model (Fig. 6). The 
MVD density can then be estimated by the equation: 
Table 1.  Correlation of MVD and MCD with Patients’ Characteristics and Tissue Histopathological Differentiation 
Histological Diagnosis  Number of Biopsies 
Microvessel Density  
(Mean ± SD) 
Mast Cell Density 
(Mean ± SD) 
Normal 5  14.08±6.08  1.32±1.02 
Leukoplakia without dysplasia  7  18.18±2.56  4.55±3.26 
Leukoplakia with dysplasia  12  21.79±6.20  7.11±3.20 
OSCC 30  24.78±  8.1  9.33±6.26 
Grade of Dysplasia   
Mild 4  19.92±5.81  7.38±  5.15 
Moderate 4  19.43±4.16  6.86±2.07 
Severe 4  22.38±3.57  6.15±  3.05 
Total 54     
 
Table 2.  Site of Lesion in Every Histologic Type 
Lesion Site 
Histological Diagnosis 
Vermilion Border  Buccal Mucosa  Tongue  Floor of the Mouth  Other Sites 
NOM  2 1 1 1 0 
Leukoplakia  without  dysplasia  2 2 2 1 0 
Leukoplakia  with  dysplasia  2 4 4 2 0 
OSCC  8 7 7 5 3 
Grade of Dysplasia   
Mild  1 1 2 0 0 
Moderate  1 2 0 1 0 
Severe  0 1 2 1 0 Mast Cells and Angiogenesis in Oral Malignant and Premalignant Lesions  The Open Dentistry Journal, 2008, Volume 2    129 
MVD=12.160 x Mast cell density 
0.283. According to this 
power curve fit model, when the density of mast cells per 
optical field reached the number of 8, no further increase in 
the density of microvessels related to the density of mast 
cells was observed.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). MVD (red arrow) and MCD (green arrow) were low in 
normal oral epithelium. (CD34 & toluidine staining, original mag-
nification X200). 
 
 
 
 
 
 
 
 
 
Fig. (2). MVD (red arrow) and MCD (green arrow) were low in 
oral leukoplakia without dysplasia similar to those of normal oral 
epithelium. (CD34 & toluidine staining, original magnification 
X200). 
DISCUSSION 
  Solid tumors, in order to outgrow the size of 2 mm
3, de-
mand for oxygen supply [23], a fact that makes necessary the 
formation of new microvasculature [5]. The process of angi-
ogenesis is the outcome of an imbalance between positive
 
and negative angiogenic factors produced by both tumor and 
host
 cells. Among the host cells, which produce and release 
in a considerable quantity  pro-angiogenic and angiogenic 
factors are mast cells [24]. Mast cells are bone marrow de-
rived, highly granulated cells, which are an important source 
of several proangiogenic and angiogenic factors, such as 
histamin and heparin [25-27], chymase [28], bFGF (FGF-2) 
[29, 30], VEGF [31].  
  TGF-beta [32] and others. Some mast cells can release 
and then rapidly synthesize VEGF [33, 34]. Within the oral 
cavity, the transformation rate of non dysplastic leukoplakia 
lesions to oral squamous cell carcinoma is estimated up to 
0.4-2 %, whereas the transformation rate of dysplastic leu-
koplakia lesions up to 9-11% [35]. The literature about the 
degree of vascularity and its correlation with mast cells in  
   
 
 
 
 
 
 
 
 
 
Fig. (3). MVD (red arrow) and MCD (green arrow) were signifi-
cantly increased in oral leukoplakia with dysplasia. (CD34 & tolu-
idine staining, original magnification X200). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (4). MVD (red arrow) and MCD (green arrow) were signifi-
cantly increased in oral squamous cell carcinoma. (Original magni-
fication X200). 
premalignant and malignant oral lesions is conflicting [36-
38]. Most of the reports though, measure mast cells and mi-
crovessels in different optical fields making their correlation 
not warranted [39]. Measuring mast cells and microvessels 
together, at the same optical field seems a more appropriate 
approach. In the current study therefore we adopted the 
counterstaing technique in order to comply with this re-
strictment. Two other reports [13, 15] in the literature also 
make an attempt towards this idea. In the current study, in 
order to measure angiogenic activity, a pan-endothelial 
marker (CD34) was used to mark microvasculature , and a 
method by Tae et al. [40] rather than the commonly used 
indirect method of Weidner [41] was adopted in order to 
count the number of microvessels. Since connective tissue is 
located just underneath the epithelium it is easier to focus on 
microvessels, at a x400 magnification, around the main le-
sion rather than deep in the connective tissue where diffusion 
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of the chromogen is often observed. In the present study, the 
density of microvessels (MVD) did increase significantly 
between normal oral mucosa and oral leukoplakia without 
dysplasia, oral leukoplakia with mild, moderate or severe 
dysplasia, and oral squamous cell carcinoma. Moreover, the  
   
 
 
 
 
 
 
 
 
 
 
Fig. (5). Mast cell (green arrow) and microvessel (red arrow) re-
vealed with toluidine blue counterstaining (Original magnification 
X400). 
 
 
 
 
 
 
 
 
 
 
Fig. (6). Power curve fit model depicting the correlation between 
MCD and MVD. 
number of microvessels was found to increase significantly 
between oral leukoplakia and oral squamous cell carcinoma. 
Therefore an angiogenic switch seems to be turned on, in 
these early stages of epithelial malignant transformation. 
This finding comes into accordance with other reports in the 
literature [42, 43], stressing the need for thorough research 
on the possible genotypic and phenotypic alterations result-
ing in this increased early angiogenic activity and on the role 
that this early angiogenic activity may play in the mecha-
nisms of epithelial malignant transformation. Moreover, in 
view of these results, a potentially different therapeutic ap-
proach during the progression from normal oral mucosa 
through leukoplakic lesions with various degrees of dyspla- 
sia to OSCC, could be discussed. At the same time, the den-
sity of mast cells (MCD) was also found to increase between 
normal oral mucosa and oral leukoplakia without dysplasia, 
oral leukoplakia with mild, moderate or severe dysplasia, 
and oral squamous cell carcinoma elucidating a possible role  
 
of these cells during the progression from normal oral tissue 
to oral squamous cells carcinoma. Several reports on a num-
ber of malignancies support the above findings [13, 15, 39] 
whereas one article so far, concerning oral squamous cell 
carcinoma, reports the opposite idea [17]. In  the current 
study, the counterstaining technique enabled the simultane-
ous observation of microvessels and mast cells at the same 
optical field. Mast cells were found to highly populate areas 
of dense vascularization (namely the ‘hot spots’) and espe-
cially around the tumor margins. It is also known that mast 
cells accumulate near sites of new capillary formation 
whereas direct association of MCs with vascular tube 
formation was clearly shown in vitro [44]. The number of 
microvessels was found to correlate significantly with the 
number of mast cells (p=0.000) in a percent 28.3%, follow-
ing the power curve fit model. This correlation is depicted by 
a certain equation: MVD=12.160 x MCD 
0.283. This finding 
come into agreement with the results from previous studies 
in oral squamous cell carcinoma 14], laryngeal squamous 
cell carcinoma [39] and other malignant tumours such as, 
squamous cell carcinoma of the oesophagus and lungs [45] 
and carcinoma of the uterine cervix [46]. According to this 
power curve fit model, when MCD per optical field reached 
the number of 8, no further increase in the number of micro- 
vessels related to the number of mast cells was observed. In 
the current study the mean number of mast cells in leukopla- 
kia with moderate dysplasia was found to be 8.47 which 
means that theoretically above the point where leukoplakia 
with dysplasia progresses to OSCC, no further increase in 
the number of microvessels related to the number of mast 
cells is present. The correlation of MVD and MCD seems, 
according to our findings, to be limited only in the early 
stages of tumorigenesis (during the transition from normal 
oral tissue through leukoplakic lesions with various degrees 
of dysplasia to OSCC) before the full transformation of 
dysplastic lesions to OSCC, giving place to other angio- 
genic stimuli or factors afterwards. The above findings could 
come up as a result of the increase in the number of mi-
crovessels allowing the infiltration with more mast cells. On 
the other hand, this direct correlation of MCD to MVD may 
be due to the proangiogenic and angiogenic activity of mast 
cells which has been proposed by previous studies [47, 48]. 
Several factors secreted by mast cells, such histamine [25], 
heparin [26], VEGF [31], bFGF [29, 30], and tryptase [27], 
have been shown to exert an activity on the migration and/or 
proliferation of endothelial cells. The number of stained mast 
cells depends on the staining technique (toluidine blue, saph- 
ranin O, tryptase immunostaining, etc.), with the tryptase 
immunostaining appearing to be the most specific for human 
mast cells [49] and the solution used for the tissue-fixing, 
with Carnoy’s solution revealing more mast cells than 
formalin [50, 51]. Moreover, there is no ideal method or 
endothelial cell marker, which specifically enumerates active 
or even all microvessel endothelial cells [12, 40, 41, 52]. It is 
in fact difficult to measure the number of microvessels and 
probably even mast cells in tissues [24]. In the present study 
the counterstaining technique was preferred in order to exert 
the possible angiogenic activity of mast cells at the same 
optical field with microvessels. More research with various 
different methods is needed to establish the above correla- 
tions and interactions. 
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CONCLUSIONS  
  According to the findings of the present study, during the 
progression from normal oral tissues through leukoplakia 
with various degrees of dysplasia to OSCC. 
1. MVD and MCD seem to be significantly increased. 
2. MCD seems to be significantly correlated to MVD.  
  The authors would like to thank Mrs Penelope Anastasia- 
dou for her technical assistance. 
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